Stem Cell Educator Therapy in Alopecia Areata
Launched by THRONE BIOTECHNOLOGIES INC. · Aug 23, 2012
Trial Information
Current as of August 11, 2025
Unknown status
Keywords
ClinConnect Summary
A 16-gauge IV needle is placed in the left (or right) median cubital vein, and the patient's blood is passed through a Blood Cell Separator MCS+ (Haemonetics®, Braintree, MA) at 35 mL/min for 6 to 7 hours to isolate lymphocytes in accordance with the manufacturer's recommended protocol. The collected lymphocytes are transferred into the device for exposure to allogeneic CB-SCs (or process control without CB-SCs), and other blood components are returned to the patient. After 2 to 3 hours in the device, lymphocytes are returned to the patient's circulation via a dorsal vein in the hand under ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients are screened for enrollment in the study if both clinical signs and laboratory tests meet the diagnosis standards recommended by the National Alopecia Areata Foundation (www.naaf.org).
- Exclusion Criteria:
- • Exclusion criteria are any clinically significant diseases in liver, kidney, and heart. Additional exclusion criteria are no pregnancy, no immunosuppressive medication, no viral diseases or diseases associated with immunodeficiency.
About Throne Biotechnologies Inc.
Throne Biotechnologies Inc. is a pioneering clinical research organization dedicated to advancing innovative therapeutic solutions in the biopharmaceutical sector. With a focus on harnessing cutting-edge biotechnology, the company is committed to developing novel treatments that address unmet medical needs across various disease indications. Throne Biotechnologies collaborates with leading academic institutions and industry partners to accelerate drug discovery and development processes, ensuring rigorous adherence to regulatory standards and clinical excellence. Through its strategic approach and expertise, Throne Biotechnologies aims to enhance patient outcomes and contribute to the evolution of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shijiazhuang, Hebei, China
Patients applied
Trial Officials
Yong Zhao, MD, PhD
Study Chair
Throne Biotechnologies Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials